Treatments for classic Kaposi sarcoma: A systematic review of the literature

Journal of the American Academy of Dermatology

Volumn 68, Issue 2, 2013, Pages 313-331

  Régnier Rosencher, Elodie ^a   Guillot, Bernard ^b   Dupin, Nicolas ^a  

^a University René Descartes ^*  (France)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

classic Kaposi sarcoma; Mediterranean Kaposi sarcoma; systematic review of literature; therapeutics

Indexed keywords

ALPHA2 INTERFERON; BLEOMYCIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IMIQUIMOD; INDINAVIR; NAVELBINE; NICOTINE; PACLITAXEL; PLACEBO; TAXANE DERIVATIVE; THALIDOMIDE; VINBLASTINE; VINCA ALKALOID; VINCRISTINE;

ALOPECIA; ARTHRALGIA; ASTHENIA; BIBLIOGRAPHIC DATABASE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CLASSIC KAPOSI SARCOMA; CLASSICAL KAPOSI SARCOMA; COCHRANE LIBRARY; CONSTIPATION; CYTOLYSIS; DIARRHEA; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ERYTHEMA; FEVER; FLU LIKE SYNDROME; HISTOPATHOLOGY; HUMAN; KAPOSI SARCOMA; LEUKOPENIA; LYMPHEDEMA; MEDLINE; META ANALYSIS; METHODOLOGY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PUBLICATION; REVIEW; SCREENING; SENSORY NEUROPATHY; SIDE EFFECT; SKIN MANIFESTATION; SKIN PRURITUS; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); THROMBOCYTOPENIA; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VERTIGO; VOMITING; WORLD HEALTH ORGANIZATION;

EID: 84872318126     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.04.018     Document Type: Review

References (49)

1. Y. Chang, E. Cesarman, M. Pessin, F. Lee, J. Culpepper, and D.M. Knowles Identification of new human herpesvirus-like DNA sequences in AIDS-Associated Kaposi's sarcoma Science 266 1994 1865 1869
2. J.W. Tappero, M.A. Conant, S.F. Wolfe, and T.G. Berger Kaposi's sarcoma: epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy J Am Acad Dermatol 28 1993 371 395
3. G. Stallone, A. Schena, B. Infante, S. Di Paolo, A. Loverre, and G. Maggio Sirolimus for Kaposi's sarcoma in renal-transplant recipients N Engl J Med 352 2005 1317 1323
4. V. Martinez, E. Caumes, L. Gambotti, H. Ittah, J.P. Morini, and J. Deleuze Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy Br J Cancer 94 2006 1000 1006
5. H. Balshem, M. Helfand, H.J. Schünemann, A.D. Oxman, R. Kunz, and J. Brozek Grade guidelines, 3: rating the quality of evidence J Clin Epidemiol 64 2011 401 406
6. D. Hauerstock, W. Gerstein, and T. Vuong Results of radiation therapy for treatment of classic Kaposi sarcoma J Cutan Med Surg 13 2009 18 21
7. S. el-Akkad, C.A. Bull, M.A. el-Senoussi, J.T. Griffin, and M. Amer Kaposi's sarcoma and its management by radiotherapy Arch Dermatol 122 1986 1396 1399
8. V. Tombolini, M.F. Osti, A. Bonanni, M. Valeriani, W. Iacari, and V. Donato Radiotherapy in classic Kaposi's sarcoma (CKS): experience of the Institute of Radiology of University "La Sapienza" of Rome Anticancer Res 19 1999 4539 4544
9. L. Chang, S. Reddy, and H. Shidnia Comparison of radiation therapy of classic and epidemic Kaposi's sarcoma Am J Clin Oncol 15 1992 200 206
10. L. Brambilla, V. Boneschi, G. Beretta, and A.F. Finzi Intralesional chemotherapy for Kaposi's sarcoma Dermatologica 169 1984 150 155
11. L. Brambilla, R. Labianca, V. Boneschi, S. Fossati, G. Dallavalle, and A.F. Finzi Mediterranean Kaposi's sarcoma in the elderly: a randomized study of oral etoposide versus vinblastine Cancer 74 1994 2873 2878
12. C.S. Costa da Cunha, C. Lebbe, M. Rybojad, F. Agbalika, F. Ferchal, and C. Rabian Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2b Arch Dermatol 132 1996 285 290
13. L. Brambilla, A. Miedico, S. Ferrucci, A. Romanelli, M. Brambati, and M. Vinci Combination of vinblastine and bleomycin as first-line therapy in advanced classic Kaposi's sarcoma J Eur Acad Dermatol Venereol 20 2006 1090 1094
14. L. Brambilla, V. Boneschi, S. Fossati, E. Melotti, and M. Clerici Oral etoposide for Kaposi's Mediterranean sarcoma Dermatologica 177 1988 365 369
15. L. Brambilla, A. Romanelli, M. Bellinvia, S. Ferrucci, M. Vinci, and V. Boneschi Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases Br J Dermatol 158 2008 1339 1344
16. L. Brambilla, R. Labianca, S. Fossati, V. Boneschi, S. Ferrucci, and M. Clerici Vinorelbine: an active drug in Mediterranean Kaposi's sarcoma Eur J Dermatol 5 1995 467 469
17. L. Brambilla, R. Labianca, S.M. Ferrucci, M. Taglioni, and V. Boneschi Treatment of classical Kaposi's sarcoma with gemcitabine Dermatology 202 2001 119 122
18. P. Monini, C. Sgadari, M.G. Grosso, S. Bellino, A. Di Biagio, and E. Toschi Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir AIDS 23 2009 534 538
19. A. Kreuter, H. Rasokat, M. Klouche, S. Esser, A. Bader, and T. Gambichler Liposomal pegylated doxorubicin versus low-dose recombinant interferon alfa-2a in the treatment of advanced classic Kaposi's sarcoma; retrospective analysis of three German centers Cancer Invest 23 2005 653 659
20. G. Di Lorenzo, A. Kreuter, R. Di Trolio, A. Guarini, C. Romano, and V. Montesarchio Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: a multicenter study J Invest Dermatol 128 2008 1578 1580
21. G. Di Lorenzo, R. Di Trolio, V. Montesarchio, G. Palmieri, P. Nappa, and M. Delfino Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma: a retrospective study Cancer 112 2008 1147 1152
22. I. Potouridou, C. Korfitis, D. Ioannidou, D. Polydorou, N. Zakopoulou, and A.J. Stratigos Low to moderate cumulative doses of pegylated liposomal doxorubicin in the treatment of classic Kaposi sarcoma in elderly patients with comorbidities Br J Dermatol 158 2008 431 432
23. E. Tur, and S. Brenner Classic Kaposi's sarcoma: low-dose interferon alfa treatment Dermatology 197 1998 37 42
24. J. Zidan, W. Robenstein, A. Abzah, and S. Taman Treatment of Kaposi's sarcoma with vinblastine in patients with disseminated dermal disease Isr Med Assoc J 3 2001 251 253
25. L. Fardet, P.-E. Stoebner, H. Bachelez, V. Descamps, D. Kerob, and L. Meunier Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection Cancer 106 2006 1785 1789
26. L. Ben M'barek, L. Fardet, A. Mebazaa, E. Thervet, I. Biet, D. Kérob, and P. Morel A retrospective analysis of thalidomide therapy in non-HIV-related Kaposi's sarcoma Dermatology 215 2007 202 205
27. J.J. Goedert, B.M. Scoppio, R. Pfeiffer, L. Neve, A.B. Federici, and L.R. Long Treatment of classic Kaposi sarcoma with a nicotine dermal patch: a phase II clinical trial J Eur Acad Dermatol Venereol 22 2008 1101 1109
28. L. Brambilla, M. Bellinvia, A. Tourlaki, B. Scoppio, F. Gaiani, and V. Boneschi Intralesional vincristine as first-line therapy for nodular lesions in classic Kaposi sarcoma: a prospective study in 151 patients Br J Dermatol 162 2010 854 859
29. G. Ghyka, M. Alecu, F. Halalau, and G. Coman Intralesional human leukocyte interferon treatment alone or associated with IL-2 in non-AIDS related Kaposi's sarcoma J Dermatol 19 1992 35 39
30. L. Brambilla, A. Tourlaki, S. Ferrucci, M. Brambati, and V. Boneschi Treatment of classic Kaposi's sarcoma-Associated lymphedema with elastic stockings J Dermatol 33 2006 451 456
31. A. Trattner, Z. Reizis, M. David, A. Ingber, J. Hagler, and M. Sandbank The therapeutic effect of intralesional interferon in classical Kaposi's sarcoma Br J Dermatol 129 1993 590 593
32. N.E. Célestin Schartz, S. Chevret, C. Paz, D. Kerob, O. Verola, and P. Morel Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: a phase I to II, open-label trial in 17 patients J Am Acad Dermatol 58 2008 585 591
33. F. Yildiz, M. Genc, S. Akyurek, M. Cengiz, E. Ozyar, and U. Selek Radiotherapy in the management of Kaposi's sarcoma: comparison of 8 gy versus 6 gy J Natl Med Assoc 98 2006 1136 1139
34. M. Caccialanza, S. Marca, R. Piccinno, and G. Eulisse Radiotherapy of classic and human immunodeficiency virus-related Kaposi's sarcoma: results in 1482 lesions J Eur Acad Dermatol Venereol 22 2008 297 302
35. C.R. Hamilton, B.J. Cummings, and A.R. Harwood Radiotherapy of Kaposi's sarcoma Int J Radiat Oncol Biol Phys 12 1986 1931 1935
36. Z. Weshler, E. Loewinger, E. Loewenthal, R. Levinson, and Z. Fuks Megavoltage radiotherapy using water bolus in the treatment of Kaposi's sarcoma Int J Radiat Oncol Biol Phys 12 1986 2029 2032
37. J.J. Goedert, F. Vitale, C. Lauria, D. Serraino, M. Tamburini, and M. Montella Risk factors for classical Kaposi's sarcoma J Natl Cancer Inst 94 2002 1712 1718
38. L.A. Anderson, C. Lauria, N. Romano, E.E. Brown, D. Whitby, and B.I. Graubard Risk factors for classical Kaposi sarcoma in a population-based case-control study in Sicily Cancer Epidemiol Biomarkers Prev 17 2008 3435 3443
39. B. Brenner, A. Weissmann-Brenner, E. Rakowsky, S. Weltfriend, E. Fenig, and R. Friedman-Birnbaum Classical Kaposi sarcoma: prognostic factor analysis of 248 patients Cancer 95 2002 1982 1987
40. G. Kroumpouzos, T. Delaney, and T.J. Phillips Combined classic and iatrogenic Kaposi's sarcoma: corticosteroid withdrawal can result in remission Postgrad Med 108 2000 103 106
41. F. Leung, A.G. Fam, and D. Osoba Kaposi's sarcoma complicating corticosteroid therapy for temporal arteritis Am J Med 71 1981 320 322
42. D. Nassar, N.E.C. Schartz, C. Bouché, A. Lévy, D. Kerob, and F. Agbalika Kaposi's sarcoma after long-Acting steroids: time until remission and drug washout Dermatology 220 2010 159 163
43. L. Brambilla, V. Boneschi, M. Taglioni, and S. Ferrucci Staging of classic Kaposi's sarcoma: a useful tool for therapeutic choices Eur J Dermatol 13 2003 83 86
44. R.T. Mitsuyasu Clinical variants and staging of Kaposi's sarcoma Semin Oncol 14 Suppl 1987 13 18
45. S.E. Krown, C. Metroka, and J.C. Wernz Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria; AIDS clinical trials group oncology committee J Clin Oncol 7 1989 1201 1207
46. R.L. Krigel, L.J. Laubenstein, and F.M. Muggia Kaposi's sarcoma: a new staging classification Cancer Treat Rep 67 1983 531 534
47. B. Brenner, E. Rakowsky, A. Katz, H. Gutman, A. Sulkes, and J. Schacter Tailoring treatment for classical Kaposi's sarcoma: comprehensive clinical guidelines Int J Oncol 14 1999 1097 1102
48. M. Janier, P. Morel, and J. Civatte The Koebner phenomenon in AIDS-related Kaposi's sarcoma J Am Acad Dermatol 22 1990 125 126
49. I. Potouridou, A. Katsambas, V. Pantazi, M. Armenaka, A. Vareltzidis, and J. Stratigos Koebner phenomenon in classic Kaposi's sarcoma Acta Derm Venereol 77 1997 481